These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 25368250
1. Effects of arsenic compounds on growth, cell-cycle distribution and apoptosis of tretinoin-resistant human promyelocytic leukemia cells. Sakai C, Arai M, Tanaka S, Onda K, Sugiyama K, Hirano T. Anticancer Res; 2014 Nov; 34(11):6489-94. PubMed ID: 25368250 [Abstract] [Full Text] [Related]
2. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Cai X, Shen YL, Zhu Q, Jia PM, Yu Y, Zhou L, Huang Y, Zhang JW, Xiong SM, Chen SJ, Wang ZY, Chen Z, Chen GQ. Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743 [Abstract] [Full Text] [Related]
3. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells]. Huang X. Chin Med J (Engl); 2000 Jun; 113(6):498-501. PubMed ID: 11775865 [Abstract] [Full Text] [Related]
4. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice. Kinjo K, Kizaki M, Muto A, Fukuchi Y, Umezawa A, Yamato K, Nishihara T, Hata J, Ito M, Ueyama Y, Ikeda Y. Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138 [Abstract] [Full Text] [Related]
5. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide. Zuo L, Li J, Yang Y, Wang X, Shen T, Xu CM, Zhang ZN. Ann Hematol; 2004 Dec; 83(12):751-8. PubMed ID: 15480664 [Abstract] [Full Text] [Related]
6. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells. Freitas RA, Silva dos Santos GA, Gimenes Teixeira HL, Scheucher PS, Lucena-Araujo AR, Lima AS, Abreu e Lima RS, Garcia AB, Jordão AA, Falcão RP, Vannucchi H, Rego EM. Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639 [Abstract] [Full Text] [Related]
7. [In vitro study on arsenic trioxide-induced apoptosis of retinoic acid resistant acute promyelocytic leukemia cell line(MR-2)]. Cai X, Jia P, Shi X. Zhonghua Xue Ye Xue Za Zhi; 1998 Jul; 19(7):339-41. PubMed ID: 11189513 [Abstract] [Full Text] [Related]
8. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells. Guo W, Wang H, Zhao W, Zhu J, Ju B, Wang X. Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431 [Abstract] [Full Text] [Related]
9. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A. Iriyama N, Yuan B, Hatta Y, Horikoshi A, Yoshino Y, Toyoda H, Aizawa S, Takeuchi J. Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758 [Abstract] [Full Text] [Related]
10. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia. Zhang P. J Biol Regul Homeost Agents; 1999 Nov; 13(4):195-200. PubMed ID: 10703942 [Abstract] [Full Text] [Related]
11. Antileukemic activity of an arsenomolybdate in the human HL-60 and U937 leukemia cells. Li C, Cao H, Sun J, Tian R, Li D, Qi Y, Yang W, Li J. J Inorg Biochem; 2017 Mar; 168():67-75. PubMed ID: 28013066 [Abstract] [Full Text] [Related]
12. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. Bernardini S, Nuccetelli M, Noguera NI, Bellincampi L, Lunghi P, Bonati A, Mann K, Miller WH, Federici G, Lo Coco F. Ann Hematol; 2006 Oct; 85(10):681-7. PubMed ID: 16733740 [Abstract] [Full Text] [Related]
13. Glycolytic metabolism confers resistance to combined all-trans retinoic acid and arsenic trioxide-induced apoptosis in HL60rho0 cells. Herst PM, Hesketh EL, Ritchie DS, Berridge MV. Leuk Res; 2008 Feb; 32(2):327-33. PubMed ID: 17580091 [Abstract] [Full Text] [Related]
14. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system. Zhu J, Okumura H, Ohtake S, Nakamura S, Nakao S. Oncol Rep; 2003 Feb; 10(3):705-9. PubMed ID: 12684647 [Abstract] [Full Text] [Related]
15. Andrographolide inhibits growth of acute promyelocytic leukaemia cells by inducing retinoic acid receptor-independent cell differentiation and apoptosis. Manikam SD, Stanslas J. J Pharm Pharmacol; 2009 Jan; 61(1):69-78. PubMed ID: 19126299 [Abstract] [Full Text] [Related]
16. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide. Jung YS, Cheong HJ, Kim SJ, Kim KH, Lee N, Park HS, Won JH. Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245 [Abstract] [Full Text] [Related]
17. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3. Jia P, Chen G, Huang X, Cai X, Yang J, Wang L, Zhou Y, Shen Y, Zhou L, Yu Y, Chen S, Zhang X, Wang Z. Chin Med J (Engl); 2001 Jan; 114(1):19-24. PubMed ID: 11779429 [Abstract] [Full Text] [Related]
18. Arsenic trioxide inhibits ATRA-induced prostaglandin E2 and cyclooxygenase-1 in NB4 cells, a model of acute promyelocytic leukemia. Habib A, Hamade E, Mahfouz R, Nasrallah MS, de Thé H, Bazarbachi A. Leukemia; 2008 Jun; 22(6):1125-30. PubMed ID: 18354491 [Abstract] [Full Text] [Related]
19. Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells. Petit A, Delaune A, Falluel-Morel A, Goullé JP, Vannier JP, Dubus I, Vasse M. Pharmacol Res; 2013 Nov; 77():11-21. PubMed ID: 24004656 [Abstract] [Full Text] [Related]
20. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia. Sahu GR, Jena RK. Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419 [Abstract] [Full Text] [Related] Page: [Next] [New Search]